Cortactin is involved in transforming growth factor-β1-induced epithelial-mesenchymal transition in AML-12 cells

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 10, 2009, Pages 839-845

  Zhang, Kehua ^a   Wang, Dongmei ^a   Song, Jianguo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Cortactin; Epithelial mesenchymal transition; Migration; Transforming growth factor

Indexed keywords

CORTACTIN; ELP3 PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE; NERVE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CYTOLOGY; EPITHELIUM CELL; HUMAN; KIDNEY; MESODERM; PHYSIOLOGY; TUMOR CELL CULTURE;

CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CORTACTIN; EPITHELIAL CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; KIDNEY; MESODERM; NERVE TISSUE PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

MURINAE;

EID: 70349599030     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp070     Document Type: Article

References (37)

1. Kalluri R and Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112: 1776-1784.
2. Nitta T, Kim JS, Mohuczy D and Behrns KE. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 2008, 48: 909-919.
3. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H and Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007, 282: 23337-23347.
4. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S and Ueberham E, et al. Hepatocyte-specific Smad7 expression attenuates TGF-b-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008, 135: 642-659.
5. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2: 442-454.
6. Grunert S, Jechlinger M and Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003, 4: 657-665.
7. Uruno T, Liu J, Zhang P, Fan Y, Egile C, Li R and Mueller SC, et al. Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol 2001, 3: 259-266.
8. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT and Cooper JA. Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 2001, 11: 370-374.
9. Lua BL and Low BC. Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett 2005, 579: 577-585.
10. Wang W, Chen L, Ding Y, Jin J and Liao K. Centrosome separation driven by actin-microfilaments during mitosis is mediated by centrosome-associated tyrosine-phosphorylated cortactin. J Cell Sci 2008, 121: 1334-1343.
11. Hill A, McFarlane S, Mulligan K, Gillespie H, Draffin JE, Trimble A and Ouhtit A, et al. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene 2006, 25: 6079-6091.
12. Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA and Chen L, et al. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 2006, 66: 8017-8025.
13. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ and Weaver AM. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 2005, 15: 1276-1285.
14. Helwani FM, Kovacs EM, Paterson AD, Verma S, Ali RG, Fanning AS and Weed SA, et al. Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization. J Cell Biol 2004, 164: 899-910.
15. Zavadil J and Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24: 5764-5774.
16. Yang Y, Pan X, Lei W, Wang J and Song J. Transforming growth factor-b1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 2006, 25: 7235-7244.
17. Weaver AM. Cortactin in tumor invasiveness. Cancer Lett 2008, 265: 157-166.
18. Chen L, Wang ZW, Zhu JW and Zhan X. Roles of cortactin, an actin polymerization mediator, in cell endocytosis. Acta Biochim Biophys Sin 2006, 38: 95-103.
19. Katsube T, Takahisa M, Ueda R, Hashimoto N, Kobayashi M and Togashi S. Cortactin associates with the cell-cell junction protein ZO-1 in both Drosophila and mouse. J Biol Chem 1998, 273: 29672-29677.
20. Yang Y, Pan X, Lei W, Wang J, Shi J, Li F and Song J. Regulation of transforming growth factor-b1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res 2006, 66: 8617-8624.
21. Zhang KH, Tian HY, Gao X, Lei WW, Hu Y, Wang DM and Pan XC, et al. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelialmesenchymal transition. Cancer Res 2009, 16: 5340-5348.
22. Campbell DH, deFazio A, Sutherland RL and Daly RJ. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines. Int J Cancer 1996, 68: 485-492.
23. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L and Toedt G, et al. Recurrent co-amplification of cytoskeletonassociated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 2006, 45: 118-125.
24. Zhang LH, Tian B, Diao LR, Xiong YY, Tian SF, Zhang BH and Li WM, et al. Dominant expression of 85-kDa form of cortactin in colorectal cancer. J Cancer Res Clin Oncol 2006, 132: 113-120.
25. Patel AS, Schechter GL, Wasilenko WJ and Somers KD. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 1998, 16: 3227-3232.
26. Kowalski JR, Egile C, Gil S, Snapper SB, Li R and Thomas SM. Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 2005, 118: 79-87.
27. van Rossum AG, Moolenaar WH and Schuuring E. Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp Cell Res 2006, 312: 1658-1670.
28. Lua BL and Low BC. BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Mol Biol Cell 2004, 15: 2873-2883.
29. Barroso C, Rodenbusch SE, Welch MD and Drubin DG. A role for cortactin in Listeria monocytogenes invasion of NIH 3T3 cells, but not in its intracellular motility. Cell Motil Cytoskeleton 2006, 63: 231-243.
30. Jia L, Uekita T and Sakai R. Hyperphosphorylated cortactin in cancer cells plays an inhibitory role in cell motility. Mol Cancer Res 2008, 6: 654-662.
31. Head JA, Jiang D, Li M, Zorn LJ, Schaefer EM, Parsons JT and Weed SA. Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell 2003, 14: 3216-3229.
32. Huang C, Ni Y, Wang T, Gao Y, Haudenschild CC and Zhan X. Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J Biol Chem 1997, 272: 13911-13915.
33. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N and Geha RS. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 2004, 24: 5269-5280.
34. van Damme H, Brok H, Schuuring-Scholtes E and Schuuring E. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J Biol Chem 1997, 272: 7374-7380.
35. Vuori K and Ruoslahti E. Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J Biol Chem 1995, 270: 22259-22262.
36. Xu J, Lamouille S and Derynck R. TGF-b-induced epithelial to mesenchymal transition. Cell Res 2009, 19: 156-172.
37. Niessen CM and Gottardi CJ. Molecular components of the adherens junction. Biochim Biophys Acta 2008, 1778: 562-571.